Joint Commission Proposes Changes to National Patient Safety Goal Related to Anticoagulant Therapy
The Joint Commission is proposing new and revised requirements under National Patient Safety Goal (NPSG) 03.05.01, Reducing Harm from Anticoagulant Therapy. The goals of the proposed changes are to address the use of the new direct oral anticoagulant (DOAC) medications including drug selection, dosing and monitoring, bleeding reversal, perioperative management and adverse drug events, promoting patient safety and quality and aligning current recommendations from scientific and professional organizations with TJC requirements.
The changes will be applicable to Hospitals, Critical Access Hospitals, Ambulatory Health Care (including ambulatory surgery centers), Office-Based Surgery, Home Care, and Nursing Care Centers.
TJC is accepting comments on the new and proposed requirements through July 31, 2018. Follow the links below to review the changes and for comment submission instructions.
Want to read the full alert and receive alert emails?